Eiko Lifesciences Allots 1.5 Lakh Shares on Warrant Conversion

Eiko Lifesciences Ltd announced the allotment of 1,50,000 equity shares following the conversion of an equal number of warrants. The conversion price was ₹55 per share, including a premium of ₹45. The company received ₹61,87,500, representing 75% of the issue price per warrant, from the allottee, Lenus Finvest Private Limited, a promoter. This conversion increases the company's issued, subscribed, and paid-up equity share capital to ₹14,80,08,540, comprising 1,48,00,854 equity shares of ₹10 each. The new shares will rank pari-passu with existing equity shares.